Europe’s medicines regulator has launched reviews into two separate safety concerns: a long-established antidepressant linked to serious neurological side effects, and a spate of unexpected allergic reactions to certain batches
Europe’s medicines regulator has launched reviews into two separate safety concerns: a long-established antidepressant linked to serious neurological side effects, and a spate of unexpected allergic reactions to certain batches